Myung Shin

Dr. Myung K. Shin is the Vice President of Discovery at Ceptur Therapeutics. Previously, he was an Executive Director of Early Discovery Genetics at Merck and Co., Inc. leading target identification and validation of human genetics targets across multiple therapeutic areas. Earlier in his career, Dr. Shin was a faculty member and PEW Scholar in Biomedical Sciences at Fox Chase Cancer Center. His research focused on Endothelin pathways during neural crest development and provided mechanistic insights into human genetics diseases such as Hirschsprung’s disease and pigment disorders. Dr. Shin received his B.A. from Northwestern University and Ph.D. in Molecular and Cell Biology from the University of California at Berkeley. Dr. Shin was a Jane Coffin Childs Postdoctoral Fellow at HHMI/Princeton University and currently serves on the Executive Advisory Board for Chemistry of Life Processes (CLP) Institute at Northwestern University.